COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,871 Articles (22,568 medRxiv, 8,303 bioRxiv)

Most recent first Previous |  Page 828: Articles 8271-8280  | Next

Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for therapy
Karim, M., Saul, S., Ghita, L., Sahoo, M. K., Ye, C., Bhalla, N., Jin, J., Park, J.-G., Martinez-Gualda, B., Patrick East, M., L. Johnson, G., Pinsky, B. A., Martinez-Sobrido, L., Asquith, C. R. M., Narayanan, A., De Jonghe, S., Einav, S.
10.1101/2022.03.18.484178 — Posted: 2022-03-20
Human Galectin-9 Potently Enhances SARS-CoV-2 Replication and Inflammation in Airway Epithelial Cells
Du, L., Bouzidi, M. S., Gala, A., Deiter, F., Billaud, J.-N., Yeung, S., Dabral, P., Jin, J., Simmons, G., Dossani, Z., Niki, T., Ndhlovu, L., Greenland, J., Pillai, S. K.
10.1101/2022.03.18.484956 — Posted: 2022-03-20
Peptidome Surveillance Across Evolving SARS-CoV-2 Lineages Reveals HLA Binding Conservation in Nucleocapsid Among Variants With Most Potential for T-Cell Epitope Loss In Spike
Wnuk, K., Sudol, J., Spilman, P. R., Soon-Shiong, P.
10.1101/2022.03.18.484954 — Posted: 2022-03-20
Durable protection against SARS-CoV-2 Omicron induced by an adjuvanted subunit vaccine
Arunachalam, P. S., Feng, Y., Ashraf, U., Hu, M., Edara, V. V., Zarnitsyna, V. I., Aye, P. P., Golden, N., Green, K. W. M., Threeton, B. M., Maness, N. J., Beddingfield, B. J., Bohm, R. P., Dufour, J., Russell-Lodrigue, K., Miranda, M. C., Walls, A. C., Rogers, K., Shirreff, L., Ferrell, D. E., Adhikary, N. R. D., Fontenot, J., Grifoni, A., Sette, A., O Hagan, D. T., Most, R. V. D., Rappuoli, R., Villinger, F. J., Kleanthous, H., Rappaport, J., Suthar, M. S., Veesler, D., Wang, T. T., King, N. P., Pulendran, B.
10.1101/2022.03.18.484950 — Posted: 2022-03-20
A Novel High-Throughput Single B-Cell Cloning Platform for Isolation and Characterization of High-Affinity and potent SARS-CoV-2 Neutralizing Antibodies
Parashar, P., B, P., Swain, S., Adhikari, N., Aryan, P., Singh, A., Kwatra, M.
10.1101/2022.03.20.485024 — Posted: 2022-03-20
Potency and Breadth of Neutralization after 3 doses of mRNA vaccines in COVID-19 Convalescent and Naive individuals
Luczkowiak, J., Rivas, G., Labiod, N., Lasala, F., Rolo, M., Lora-Tamayo, J., Mancheno-Losa, M., Rial-Crestelo, D., Folgueira, M. D., Delgado, R.
10.1101/2022.03.17.22272557 — Posted: 2022-03-20
Evaluation of a throat spray with lactobacilli in COVID-19 outpatients in a randomized, double-blind, placebo-controlled trial for symptom and viral load reduction
De Boeck, I., Cauwenberghs, E., Spacova, I., Gehrmann, T., Eilers, T., Delanghe, L., Wittouck, S., Bron, P. A., Henkens, T., Gamgami, I., Simons, A., Claes, I., Marien, J., Arien, K. K., Bakokimi, D., Loens, K., Jacobs, K., Ieven, M., Bruijning-Verhagen, P., Delputte, P., Coenen, S., Verhoeven, V., Lebeer, S.
10.1101/2022.03.17.22272401 — Posted: 2022-03-20
Validity of reported post-acute health outcomes in children with SARS-CoV-2 infection: a systematic review
Hirt, J., Janiaud, P., Gloy, V., Schandelmaier, S., Pereira, T. V., Contopoulos-Ioannidis, D. G., Goodman, S. N., Ioannidis, J. P. A., Munkholm, K., Hemkens, L. G.
10.1101/2022.03.18.22272582 — Posted: 2022-03-20
Association of Periodic Fasting with Lower Severity of COVID-19 Outcomes in the SARS-CoV-2 Pre-Vaccine Era: An Observational Cohort from the INSPIRE Registry
Horne, B. D., Muhlestein, J. B., May, H. T., Le, V. T., Bair, T. L., Knowlton, K. U., Anderson, J. L.
10.1101/2022.03.17.22272577 — Posted: 2022-03-20
SARS-CoV-2 infections in infants in Haiti 2020-2021; evidence from a serological cohort
Louis, R., Pu, R., Logan, T., Trimmer-Smith, L., Chamblain, R., Gallagher, A., Beau De Rochars, V. M., Nelson, E. J., Cummings, D. A. T., Long, M., Morris, J. G.
10.1101/2022.03.17.22272561 — Posted: 2022-03-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).